The drugs manufacturer had   doses of suvorexant as high as  milligrams In addition to the maximum dose of  milligrams the FDA has approved milligram milligram and milligram doses of the medication and recommended that those with insomnia use the lowest possible dose of the medication to avoid drowsiness lasting into the next day The agency also has required the manufacturer to conduct a study of nextday driving performance in those taking Belsomra An estimated  to  of Americans are thought to suffer from insomnia Most patients who seek medication to go to sleep faster or to stay asleep are prescribed a class of drugs called hypnotics including medications in the benzodiazepine family sold under such commercial names as Xanax Ativan Restoril and Halcion and nondiazepine hypnotics sold under such commercial names as Zaleplon Ambien Lunesta and Ramelteon Belsomra acts as an inhibitor of the brains orexin neurons in its arousal circuits In clinical trials submitted to the FDA after three months use it caused subjects to fall asleep between  and  minutes more quickly than did subjects taking a placebo And compared to subjects taking the placebo those taking the medications proposed low dose for three months stayed asleep for  to  minutes longer per night The manufacturer said Wednesday that it expects the new prescription drug to be in pharmacies in late  or early 